Products for administering an initial high dose of Cetrorelix and producing a combination package for use when treating diseases
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Sep 2, 1997
Grant Date -
N/A
app pub date -
Dec 8, 1994
filing date -
Dec 9, 1993
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
For application during the treatment of benign and malign tumour diseases, the product according to the invention containing the initial dose of Cetrorelix acetate and one or more maintenance doses of Cetrorelix acetate, Cetrorelix embonate or a slow-release form of Cetrorelix, is used as a combination preparation for treatment to be administered at specific time intervals.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully